Stay updated on CHF5993 pMDI vs Symbicort Turbuhaler in COPD Clinical Trial
Sign up to get notified when there's something new on the CHF5993 pMDI vs Symbicort Turbuhaler in COPD Clinical Trial page.

Latest updates to the CHF5993 pMDI vs Symbicort Turbuhaler in COPD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This represents a minor maintenance update to the page's documentation rather than changes to study data or functionality.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a small metadata update to the ClinicalTrials.gov record.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page now displays a recruitment status banner 'No longer looking for participants' and adds new help/navigation items ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), with the Intervention header updated from 'Intervention / Treatment' to 'Intervention/Treatment' and a new page revision note 'Revision: v3.6.0'.SummaryDifference0.2%

- Check48 days agoChange DetectedAn updated revision tag was added, replacing v3.5.4 with v3.5.5, indicating a new version of the study protocol and related documents. This change reflects an internal document revision rather than a modification to public-facing content or results.SummaryDifference0.0%

- Check55 days agoChange DetectedClinicalTrials.gov entry NCT03197818 for TRIVERSYTI now shows posted results, including final analyses of screened and randomized patients and multiple outcome measures (lung function, QoL, and health economics). The update also documents run-in procedures, remote visit adaptations due to COVID-19, and the extensive list of participating sites.SummaryDifference9%

- Check70 days agoChange DetectedPage revision updated from v3.5.3 to v3.5.4, indicating a newer version of the page publication. This change appears to affect metadata rather than substantive study content.SummaryDifference0.0%

Stay in the know with updates to CHF5993 pMDI vs Symbicort Turbuhaler in COPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CHF5993 pMDI vs Symbicort Turbuhaler in COPD Clinical Trial page.